Rationale: Hyperhomocysteinemia contributes to vascular dysfunction and risks of cardiovascular diseases. Stromal cell-derived factor (SDF)-1, a chemokine expressed by endothelial cells (ECs), is highly expressed in advanced atherosclerotic lesions. The interplays among homocysteine, chemokines, and shear stress in regulating vascular endothelial function are not clearly understood. Objective: To investigate the mechanisms for modulations of EC SDF-1 expression by homocysteine and shear stress. Methods and Results: Homocysteine stimulation induced dose-and time-dependent SDF-1 expression and phosphorylation of mitogen-activated protein kinases extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. By using specific inhibitors, small interfering (si)RNA, and dominant negative mutants, we demonstrated that activation of JNK pathway is critical for the homocysteine-induced SDF-1 expression. Transcription factor ELISA and chromatin immunoprecipitation assays showed that homocysteine increased Sp1-and AP-1-DNA binding activities in ECs. Inhibition of Sp1 and AP-1 activations by specific siRNA blocked the homocysteine-induced SDF-1 promoter activity and expression. Preshearing of ECs for 1 to 4 hours at 20 dyn/cm 2 inhibited the homocysteine-induced JNK phosphorylation, Sp1 and AP-1 activation, and SDF-1 expression. The homocysteine-induced SDF-1 expression was suppressed by NO donor. Inhibitor or siRNA for endothelial NO synthase abolished the shear inhibition of SDF-1 expression. Conclusions: Our findings serve to elucidate the molecular mechanisms underlying the homocysteine induction of SDF-1 expression in ECs and the shear stress protection against this induction. (Circ Res. 2009;105:755-763.)
SDF-1 expression in pathophysiological conditions such as hyperhomocysteinemia is still unknown.
Homocysteine is a sulfur-containing amino acid formed during the metabolic demethylation of methionine. Elevated blood levels of homocysteine are related to higher risks of coronary heart disease, stroke, and peripheral vascular disease. 13 Homocysteine may promote vascular damage and atherothrombosis via several mechanisms, including release of proinflammatory mediators, induction of endothelial dysfunction, and activation of apoptotic pathways in vascular cells. 14 The relationship between the plasma levels of homocysteine and SDF-1, the mechanisms underlying homocysteine-induced SDF-1 expression, and the role of shear stress in the modulation of homocysteine-induced gene expression still remain unclear.
We aimed to establish the relationship between plasma homocysteine and SDF-1 levels in human blood and the interplay between shear stress and homocysteine stimulation in modulating endothelial gene expression by analyzing the effect of shear stress on homocysteine-induced SDF-1 expression in human umbilical vein endothelial cells (HUVECs) and human aortic endothelial cells (HAECs). We found that the induction of SDF-1 expression by homocysteine was mediated via phosphorylation of c-Jun N-terminal kinase (JNK) and activation of the transcription factors (TFs) activator protein (AP)-1 and Sp1. Furthermore, fluid shear stress attenuated the homocysteine-induced SDF-1 expressions at mRNA and protein levels, and ECs subjected to shear stress suppress the homocysteine-induced JNK phosphorylation and TF activation. In addition, homocysteine-induced SDF-1 expression was modulated by nitric oxide (NO): an NO donor suppressed homocysteine-induced SDF-1 expression, and inhibition of endothelial NO synthase (eNOS) attenuated shear stress inhibition of SDF-1 expression. These findings on the mechanisms of suppression of homocysteineinduced responses in ECs by shear stress provide new insights into the pathophysiology underlying the atheroresistance of straight segments of vascular tree.
Methods
Detailed information regarding materials and procedures for the following: subjects; measurement of plasma homocysteine; SDF-1 ELISA; EC culture; shear stress experiment; real-time quantitative polymerase chain reaction (PCR); Western blot analysis; reporter gene construct, small interfering (si)RNA, transfection, and luciferase assays; adenoviral infection; Sp1 and AP-1 TF assays (TF ELISAs); chromatin immunoprecipitation (ChIP) assay; and statistical analysis are provided in the Online Data Supplement at http://circres.ahajournals.org.
Results

Relationship Between Plasma Levels of Homocysteine and SDF-1
The mean plasma homocysteine concentration was significantly higher in high-risk patients (30.94Ϯ4.13 mol/L) than normal volunteers (14.08Ϯ1.02 mol/L). Linear regression shows a positive correlation between plasma homocysteine and SDF-1 levels in patients ( Figure 1A ; rϭ0.81, PϽ0.0001) and volunteers ( Figure 1B ; rϭ0.51, PϽ0.001). Linear regression of data combined the 2 groups was showed in Online Figure I (rϭ0.79, PϽ0.0001). We divided all subjects (patients plus normal volunteers) according to their plasma homocysteine levels into normal (Ͻ15 mol/L, nϭ24, 10 from patients), mild (16 to 30 mol/L, nϭ36, 11 from patients), and intermediate (31 to 100 mol/L, nϭ12, 11 from patients) hyperhomocysteinemia. 15 Plasma SDF-1 level was significantly higher in subjects with intermediate hyperhomocysteinemia than normal or mild hyperhomocysteinemia ( Figure 1C ), indicating that higher levels of plasma homocysteine were associated with higher SDF-1.
Homocysteine-Induced SDF-1 Expression is Doseand Time-Dependent
HUVECs and HAECs were stimulated with homocysteine at 100 mol/L for the times indicated, or different doses (0 to 500 mol/L) for 4 hours (for mRNA expression by real-time PCR) and 12 hours (for protein secretion by ELISA). In ECs, the SDF-1 mRNA level began to increase after 1 hour of homocysteine stimulation and reached highest level at 4 hours; thereafter, it gradually reduced to a level that is not significantly different from the static control in HUVECs at 12 hours but was still elevated at this time in HAECs ( Figure  2A ). SDF-1 protein in the conditioned medium also increased after stimulation ( Figure 2C ). The inductions of SDF-1 mRNA expression and protein secretion by homocysteine were dose-dependent ( Figure 2B and 2D).
The viability of ECs was Ͼ94% when cultured for 24 hours with 20 to 200 mol/L homocysteine and 87% with 500 mol/L homocysteine (data not shown).
Homocysteine-Induced SDF-1 Expression in EC Was Mediated by JNK Pathway
Members of the mitogen-activated protein kinase superfamily are known to regulate EC gene expression and cellular functions. 16 The phosphorylation of extracellular signalregulated kinase (ERK), JNK, and p38 in HUVECs increased rapidly after homocysteine stimulation, reaching maximal levels at 2 minutes for ERK and JNK, and 5 minutes for p38 ( Figure 3A ). After transient increases, phosphorylation decreased to nearly basal levels. (Online Figure II shows that JNK phosphorylation decreased to control at 60 minutes, but ERK and p38 phosphorylations were still elevated at 120 minutes.) HUVECs were incubated with specific inhibitors for ERK (PD98059; 30 mol/L), JNK (SP600125; 20 mol/L), or p38 (SB203580; 10 mol/L) for 1 hour before and during stimulation with homocysteine. The homocysteine-induced SDF-1 mRNA expression ( Figure 3B ) and protein secretion ( Figure 3C ) were significantly inhibited by SP600125, but not by PD98059 and SB203580. The homocysteine-induced SDF-1 mRNA expression was also inhibited by transfection with JNK-specific siRNA or infection with adenoviral dominant negative JNK (Ad-DN-JNK), but not by ERK-or p38-specific siRNA (100 mol/mL each), nor with Ad-DN-ERK nor Ad-DN-p38 ( Figure 3D ). The effectiveness of these treatments was validated: ERK-, JNK-, and p38-specific siRNA (compared with control siRNA) caused a 75% reduction in ERK, JNK, and p38 protein expressions, respectively (data not shown). The DN-ERK, DN-JNK, and DN-p38 caused at least 80% inhibitions in homocysteine-induced ERK, JNK, and p38 phosphorylation (compared with control Ad-GFP) (data not shown).
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AP-1-and Sp1-Binding Sites Are Essential for the Homocysteine Induction of Human SDF-1 Promoter Activity
The human SDF-1 gene promoter contains multiple TF binding sites, which have been shown to be responsive to different stimuli. 17 To elucidate the cis-acting elements in the SDF-1 gene promoter that mediate the homocysteine-induced SDF-1 transcription, luciferase assay was conducted with p-1010-Luc plasmid and several deletion promoters constructs ( Figure 4A ). Transient transfection of ECs showed that the 5Ј-flanking region of human SDF-1 (Ϫ1010/ϩ122) could drive transcription of a luciferase reporter ( Figure 4B ). Construction and analyses of 5Ј-deletion mutants in the Ϫ1010/ϩ122 region of SDF-1, which directed maximum luciferase activity, showed that the activity decreased to Ϸ45% following sequence deletion from Ϫ430 to Ϫ214, to Ϸ75% after further deletion to Ϫ111, and was nearly abolished following 5Ј deletion to Ϫ20 ( Figure 4B ).
To test whether AP-1 and Sp1 activations are involved in the signal transduction pathway leading to the homocysteineinduced SDF-1 gene expression, we transfected HUVECs with siRNA of Sp1 or c-jun, or incubated them with the specific inhibitor for Sp1 (mithramycin A, 100 nmol/L) for 1 hour, before stimulation with 50 or 100 mol/L homocysteine for 4 hours. The homocysteine-induced SDF-1 mRNA expression ( Figure 4C ) and SDF-1 promoter activity ( Figure  4D ) were significantly reduced by inhibition with mithramycin A or siRNA of Sp1 or c-jun.
Homocysteine Induced Sp1-and AP-1-DNA Binding Activities
To investigate whether Sp1 and AP-1 bind the SDF-1 promoter region in HUVECs, we performed quantitative analysis for Sp1-and AP-1-binding activities in vitro by using TF ELISA kits (Panomics). Treatment of HUVECs with 100 mol/L homocysteine caused both Sp1-and AP-1-DNA binding activities to increase at 30 minutes and remain elevated for at least 2 hours ( Figure 5A and 5B, respectively).
ChIP analysis was performed by subjecting immunoprecipitated chromosomal DNA with anti-Sp1 antibody to PCR using primers designed to amplify the SDF-1 promoter region harboring the Sp1-binding sites. Sp1 indeed bound to the SDF-1 promoter region containing the Sp1 sites ( Figure 5C ). Similarly, the DNA sequence including the AP-1 sites was specifically immunoprecipitated with antic-jun antibody (Figure 5D ). These data suggested that the Sp1 and AP-1-binding sites play critical roles in the regulation of SDF-1 by homocysteine.
JNK Signaling Pathway Was Involved in Homocysteine-Induced SDF-1 Promoter Activity
To evaluate whether the inhibition of SDF-1 expression by JNK signaling pathway occurred at the transcriptional level, To explore whether JNK activates the SDF-1 promoter leading to SDF-1 transcription via activation of Sp1 and AP-1, HUVECs were pretreatment with mitogen-activated protein kinase inhibitors, transfection with JNK siRNA, or infection with Ad-DN-JNK, followed by homocysteine stimulation, and then the Sp1 and AP-1 activations were assessed by TF ELISA kits. Homocysteine-induced AP-1 and Sp1-DNA binding activities were significantly inhibited in cells pretreatment with SP600125, JNK siRNA, or Ad-DN-JNK but not in pretreatment with PD98059, SB203580, control siRNA, or Ad-GFP ( Figure 6B and 6C).
Preexposure of ECs to High Shear Stress Inhibited Homocysteine-Induced SDF-1 Expression
Preexposure of ECs to high shear stress (HSS) at 20 dyn/cm 2 for 4 hours significantly inhibited homocysteine-induced SDF-1 mRNA expression ( Figure 7A ), and this effect is shear time-dependent in HUVECs (Online Figure III) . Low shear stress (LSS) at 0.5 dyn/cm 2 did not have such an effect. Both HSS and LSS alone had no significant effect on SDF-1 expression ( Figure 7A ). In addition, HUVECs cultured on fibronectin or collagen type I and preexposed to HSS for 4 hours had similar inhibitory effect on homocysteine-induced SDF-1 expression (Online Figure IV) . Preexposure of HUVECs to HSS resulted in a marked inhibition of the homocysteine-induced JNK phosphorylation ( Figure 7B ). Preexposure of HUVECs to HSS also resulted in a significant inhibition of the homocysteine-induced SDF-1 promoter activity (Online Figure V) .
Preshearing of HUVECs at HSS for 4 hours significantly inhibited the homocysteine-induced Sp1-and AP-1-DNA binding activities in vivo by ChIP assays (Figure 7C and 7D) and in vitro by using TF ELISA kits (Online Figure VI, A and  B) . These results provide additional evidence that shear stress plays an important role in the inhibition of the JNK-, Sp1-, and AP-1-mediated SDF-1 expression in ECs induced by homocysteine stimulation. 
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Effect of NO on Homocysteine-Induced SDF-1 Expression
A major effect of hyperhomocysteinemia-induced EC dysfunction appears to be related to decreased bioavailability of EC-derived NO. 18 To investigate whether the homocysteineinduced SDF-1 expression is modulated by NO, both HUVECs and HAECs were incubated with different doses of the NO donor S-nitroso-N-acetyl-penicillamine (SNAP) for 4 hours before and during stimulation with homocysteine. The homocysteine-induced mRNA expression of EC SDF-1 was significantly inhibited by 20 to 100 mol/L SNAP treatment ( Figure 8A) . Conversely, addition of 100 mol/L N G -nitro-L-arginine methyl ester (L-NAME) or transfection of eNOS siRNA before exposure to 4 hours of HSS abolished the shear-mediated inhibition of SDF-1 expression ( Figure 8B ). These results indicated that NO plays an important role in the homocysteine-induction and shear inhibition of SDF-1 expression in ECs.
Discussion
The production of proinflammatory factors in vascular cells play an important role in atherogenesis. 19, 20 SDF-1 is a potent chemokine that recruits mononuclear cells to the inflamed tissues 10, 11 and has been shown to be highly expressed in human atherosclerotic plaques. 12 Moreover, increased levels of blood SDF-1 have been associated with stable coronary disease, 21 and SDF-1 is likely to be involved in neointimal hyperplasia or thrombus formation after injury. 22 The ability of homocysteine to stimulate SDF-1 gene expression in ECs may lead to the elevation of SDF-1 in the circulation during hyperhomocysteinemia. The mechanism by which homocysteine regulates SDF-1 gene expression of ECs, however, remains unclear. The novel findings of the present study are (Online Figure VII) : (1) plasma homocysteine is positively correlated with SDF-1 in both high-risk patients and normal volunteers; (2) homocysteine stimulates SDF-1 mRNA expression and protein secretion in ECs; (3) homocysteine- Before being kept as controls or stimulated with homocysteine, ECs were pretreated with 20 to 100 mol/L SNAP for 4 hours. *PϽ0.05 vs CL HUVECs; #PϽ0.05 vs CL HAECs; &PϽ0.05 vs methanol (MeOH)-treated HUVECs (vehicle control) with homocysteine stimulation; @PϽ0.05 vs MeOH-treated HAECs with homocysteine stimulation. B, ECs were kept as controls or presheared at HSS (20 dyn/cm 2 ) for 4 hours before homocysteine stimulation. Before preshearing, ECs were pretreated with 100 mol/L L-NAME for 4 hours or transfected with si-CL or si-eNOS. Static ECs were stimulated with homocysteine without preshearing (static). *PϽ0.05 vs CL, vesicle control (HSSϩMeOH), or control siRNA (HSSϩsi-CL) HUVECs with homocysteine stimulation; #PϽ0.05 vs CL, vesicle control (HSSϩMeOH), or control siRNA (HSSϩsi-CL) HAECs with homocysteine stimulation; &PϽ0.05 vs L-NAME-treated (HSSϩL-NAME) or eNOS siRNA-transfected (HSSϩsi-eNOS) HUVECs with homocysteine stimulation; @PϽ0.05 vs L-NAME-treated (HSSϩL-NAME) or eNOS siRNA-transfected (HSSϩsi-eNOS) HAECs with homocysteine stimulation.
induced SDF-1 expression in ECs is mediated via JNK phosphorylation and Sp1 and AP-1 activation; (4) shear stress attenuates the homocysteine-induced SDF-1 expression; and (5) the effect of homocysteine and shear stress on EC SDF-1 expression is mediated by NO.
The results of this study demonstrate that homocysteine not only promotes the secretion of SDF-1 but also induces their gene transcription and expression in human ECs. Analysis of the human SDF-1 promoter activity with different plasmid constructs revealed that AP-1 and Sp1 function as the cis-element for homocysteine responsiveness via JNK phosphorylation. SDF-1 promoter has different binding sites for various transcriptional factors. 17 Previous studies have shown that Sp1 23 and AP-1 24 can be activated through the JNK pathway in ECs. Regulation of gene expression through the use of combinations of different TFs such as Sp1 and AP-1 has been reported, 25, 26 and JNK is involved in the phosphorylation and activation of c-Jun. 27 In this study, we performed luciferase assays to show that Sp1 and AP-1 cooperate to activate the human SDF-1 promoter and we used TF ELISA and ChIP assays to demonstrate that the regulation of SDF-1 gene expression in ECs was mediated by increased Sp1-and AP-1-DNA binding activities following JNK phosphorylation. A previous study has shown that Sp1 induces a conformational change in the DNA that may contribute to the activation of AP-1 binding. 28 The molecular details of Sp1 and AP-1 cooperation in activating the SDF-1 promoter need further investigations. Based on our results, we propose a possible signal transduction pathway in ECs in which homocysteine induces JNK phosphorylation, which activates Sp1 and AP-1, thus resulting in SDF-1 transcriptional activation.
Hyperhomocysteinemia has been defined as a plasma concentration of homocysteine exceeding 15 mol/L and is considered severe at levels of Ͼ100 mol/L. 15 Severe hyperhomocysteinemia caused by genetic disorders usually involves homocysteine concentrations of Ͼ100 mol/L. When untreated, affected individuals have a 50% chance of developing a major vascular disease. 18 Mild hyperhomocysteinemia is quite prevalent in the general population (plasma homocysteine 15 to 50 mol/L) but also has been shown to be associated with increased risks for cardiovascular diseases. 29, 30 Previous studies have demonstrated that homocysteine might induce the expression of chemokines, eg, monocyte chemoattractant protein (MCP)-1 and interleukin-8 in human monocytes and aortic ECs, 31, 32 and MCP-1 in human vascular smooth muscle cells. 33 Homocysteine not only promotes the secretion of MCP-1 and interleukin-8 in human monocytes but also enhances the responsiveness of monocytes to MCP-1 in hyperhomocysteinemia patients. 31 The present findings of a positive correlation of plasma homocysteine with SDF-1 levels and the elevation of SDF-1 in patient groups suggest that SDF-1 may play an important role in the pathogenesis of cardiovascular diseases. Furthermore, our results on human EC cultures showed that treatment with homocysteine concentrations characterizing mild to severe hyperhomocysteinemia (20 to 500 mol/L) has stimulatory effects on SDF-1 expression. Therefore, hyperhomocysteinemia might provide an effective stimulus for SDF-1 accumulation in the arterial wall, thus promoting the recruitment of leukocytes and contributing to proinflammatory responses.
The endothelial lining of the vasculature plays an important role in sensing blood flow perturbations, leading to the modulation of gene expression in EC. At vessel bifurcations in an arterial tree, disturbed flow accompanied by LSS predisposes ECs to inflammation in which proinflammatory factors are involved; in contrast, laminar shear stress with a clear direction exerts atheroprotective effects. 34, 35 Our study showed that homocysteine-induced SDF-1 upregulation was inhibited in ECs subjected to HSS with a clear direction. Preexposure of ECs to a high level of shear stress inhibited homocysteine-induced signal transduction and SDF-1 expression. Previous studies demonstrated that shear stress also induced JNK activation in ECs and that this shear effect was dependent on the specific extracellular matrix. 36, 37 However, the shearinduced JNK activation seemed to be dependent on cell type and culture conditions. In our experiments, HUVECs cultured on fibronectin or collagen type I had similar inhibitory effect on homocysteine-induced SDF-1 expression. It is likely that shear stress modulates inflammatory responses by other mechanisms. Berk et al 38 reported that shear stress induced greater extent of ERK activation and that the ERK activation then repressed JNK activation in HUVECs, indicating that ERK pathway may mediate the shear stress suppression of JNK. Yoshizumi et al 39 suggested that the possible mechanisms for this ERK-induced suppression include the JNK phosphatases and JNK interacting proteins. The tyrosine phosphatase activity of SHP-2 appears to be required for tumor necrotic factor ␣-induced signaling pathways. Inhibition of the phosphatase activity by shear stress represents a presumable mechanism by which shear stress modulates inflammatory factor-induced signal transduction. Therefore, elucidation of the mechanisms in homocysteine-and shear-mediated signal transduction requires further studies on ECs by manipulating activities of other upstream or downstream signaling proteins.
NO has been recognized to be an antiinflammatory molecule. It is produced by eNOS in response to physiological stimuli such as acetylcholine, thrombin, or shear stress. 40 There is evidence in support of a role of NO in the regulating of gene expression in vascular cells. Endogenous NO production inhibited cytokine-induced expression of adhesion molecules as well as leukocyte adhesion. 41 Exogenous addition of NO decreased MCP-1 expression in human ECs 42 and also inhibited the expression of MCP-1 in smooth muscle cells. 43 Previously observations showed that homocysteine decreases NO bioavailability in cultured ECs. 18, 44 In addition, homocysteine-induced EC apoptosis was inhibited by NO. 45 In this study, administration of a SNAP significantly suppressed homocysteine-induced SDF-1 expression. Furthermore, NO produced from eNOS in response to shear stress has been shown to play a crucial role in shear-mediated antiatherogenic effects. 46 Decreased bioavailability of NO may contribute to thrombosis and atherosclerosis, because the prominent effects of ECderived NO produced in response to shear stress include vessel relaxation and inhibition of cytokine-triggered platelet and monocyte adhesion. 46 Our findings on the effects of L-NAME and eNOS siRNA on the shear-induced inhibition in SDF-1 expression in ECs are in concert with the hypothesis that NO may play a role in the shearmediated suppression of proatherogenic factor-regulated genes. Preexposure of ECs to 4 hours of HSS inhibited homocysteine-induced SDF-1 expression, and this shear effect was blocked by treatment of L-NAME and transfection of eNOS siRNA. Thus, our findings also indicate that EC-derived NO may mediate homocysteine-induced SDF-1 expression in human ECs.
In summary, the present study demonstrates for the first time an increased expression of SDF-1 in ECs and in the circulating blood during hyperhomocysteinemia. This study has identified a unique molecular mechanism of homocysteine-induced JNK phosphorylation, Sp1 and AP-1 activations, and SDF-1 expression in ECs. Our findings provide a molecular basis for the mechanisms underlying the protective function of laminar shear stress against this SDF-1 induction. 
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